Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis

被引：0

作者：

Lai-Chu See

Hsin-Fu Lee

Tze-Fan Chao

Pei-Ru Li

Jia-Rou Liu

Lung-Sheng Wu

Shang-Hung Chang

Yung-Hsin Yeh

Chi-Tai Kuo

Yi-Hsin Chan

Gregory Y. H. Lip

机构：

[1] Chang Gung University,Department of Public Health, College of Medicine

[2] Chang Gung University,Biostatistics Core Laboratory, Molecular Medicine Research Center

[3] Division of Rheumatology,College of Medicine

[4] Allergy and Immunology,Graduate Institute of Clinical Medical Sciences, College of Medicine

[5] Department of Internal Medicine,Institute of Clinical Medicine, Cardiovascular Research Center

[6] Chang Gung Memorial Hospital,Liverpool Centre for Cardiovascular Science

[7] The Cardiovascular Department,undefined

[8] Chang Gung Memorial Hospital,undefined

[9] Chang Gung University,undefined

[10] Chang Gung University,undefined

[11] New Taipei City Municipal Tucheng Hospital,undefined

[12] Chang Gung Memorial Hospital,undefined

[13] Tucheng branch,undefined

[14] Division of Cardiology,undefined

[15] Department of Medicine,undefined

[16] Taipei Veterans General Hospital,undefined

[17] National Yang-Ming University,undefined

[18] Center for Big Data Analytics and Statistics,undefined

[19] Chang Gung Memorial Hospital,undefined

[20] Microscopy Core Laboratory,undefined

[21] Chang Gung Memorial Hospital,undefined

[22] University of Liverpool and Liverpool Heart & Chest Hospital,undefined

来源：

Cardiovascular Drugs and Therapy | 2021年 / 35卷

关键词：

Atrial fibrillation; Direct thrombin inhibitor; Dialysis; Factor Xa inhibitor; Ischemic stroke; Hemorrhage; Mortality; End-stage renal disease; Warfarin;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：975 / 986

页数：11

共 213 条

[1]

Wolf PA(1991)Atrial fibrillation as an independent risk factor for stroke: the Framingham study Stroke 22 983-988

[2]

Abbott RD(2018)Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report Chest 154 1121-1201

[3]

Kannel WB(2019)AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons Circulation 140 e125-ee51

[4]

Lip GYH(2016)Nonvitamin K anticoagulant agents in patients with advanced chronic kidney disease or on dialysis with AF J Am Coll Cardiol 67 2888-2899

[5]

Banerjee A(2018)The 2018 European heart rhythm association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation Eur Heart J 39 1330-1393

[6]

Boriani G(2010)Simplifying stroke risk stratification in atrial fibrillation patients: implications of the CHA2DS2-VASc risk stratification scores Age Ageing 39 533-535

[7]

Chiang CE(2010)Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the euro heart survey Chest 138 1093-1100

[8]

Fargo R(2014)The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments Stat Med 33 1242-1258

[9]

Freedman B(2013)A tutorial on propensity score estimation for multiple treatments using generalized boosted models Stat Med 32 3388-3414

[10]

January CT(2011)An introduction to propensity score methods for reducing the effects of confounding in observational studies Multivariate Behav Res 46 399-424

← 1 2 3 4 5 6 7 8 9 10 →